Cutaneous diseases of the foot: Unapproved treatments

Clinics in Dermatology

Volumn 20, Issue 6, 2002, Pages 689-699

  Katsambas, Andreas ^a,b   Stefanaki, Christine ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ADRENALIN; ALPHA INTERFERON; ANTIFUNGAL AGENT; BLEOMYCIN; CANTHARIDIN; CIDOFOVIR; CIMETIDINE; COLLAGEN; DIPHENCYPRONE; FLUOROURACIL; FORMALDEHYDE; GLUTARALDEHYDE; IMIQUIMOD; LEVAMISOLE; NICKEL; PICIBANIL; PODOPHYLLIN; PODOPHYLLOTOXIN; PYRROLE DERIVATIVE; PYRUVIC ACID; SALICYLIC ACID; SILVER NITRATE; SOLCODERM; SQUARIC ACID DIBUTYL ESTER; TOLNAFTATE; TRICHLOROACETIC ACID; UNDECANOIC ACID; UNINDEXED DRUG; WHITFIELD OINTMENT;

CAUTERIZATION; CLINICAL TRIAL; CRYOTHERAPY; DYSHIDROSIS; EROSION; ERYTHEMA; FOOT DISEASE; HOMEOPATHY; HUMAN; HYPERHIDROSIS; HYPERTHERMIC THERAPY; PRIORITY JOURNAL; PULSED DYE LASER; PUSTULOSIS PALMOPLANTARIS; REVIEW; SIDE EFFECT; SKIN DISEASE; SKIN INFECTION; SKIN SURGERY; TINEA PEDIS; VERRUCA VULGARIS;

EID: 0036865104     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(02)00291-2     Document Type: Article

References (164)

1. Kilkenny M., Merlin K., Young R., et al. Thru prevalence of common skin conditions in Australian school students Common, plane and plantar viral warts . Br J Dermatol. 138:1998;840-845.
2. Messing A.M., Epstein W.L. Natural history of warts. A two-year study. Arch Dermatol. 87:1963;306.
3. Baker G.E., Tyring S.K. Therapeutic approaches to papilloma virus infections. Dermatol Clin. 15:1997;331-340.
4. Van Scott E.J., Yu R.J. Alpha hydroxy-acids. Procedures for use in clinical practice. Cutis. 43:1989;222-228.
5. Van Scott E.J., Yu R.J. Alpha hydroxy acids Therapeutic potentials . Can J Dermatol. 1:1989;108-111.
6. Halasz C.L.G. Treatment of warts with topical pyruvic acid with and without added 5-fluorouracil . Cutis. 62:1998;283-285.
7. Hursthouse M.W. A controlled trial on the use of topical 5-fluorouracil on viral warts. Br J Dermatol. 92:1975;93-96.
8. Parish L.C., Witkowski J.A. Traditional therapeutic agents. Clin Dermatol. 18:2000;5-9.
9. Sanchez M.R. Miscellaneous treatments Thalidomide, potassium iodide, levamisole, clofazimine, colchicine, and D-penicillamine . Clin Dermatol. 18:2000;131-145.
10. Yazar S., Basaran E. Efficacy of silver nitrate pencils in the treatment of common warts. J Dermatol. 21:1994;329-333.
11. Burri P. Treatment of naevi and warts by topical chemotherapy with solcoderm. Dermatologica. 21:1994;52.
12. London I.D. Buffered glutaraldehyde solution for warts. Arch Dermatol. 104:1971;96-97.
13. London I.D. 25% glutaraldehyde solution for warts. Arch Dermatol. 104:1971;440.
14. Allenby C.F. The treatment of viral warts with glutaraldehyde. Br J Clin Prac. 31:1977;12-13.
15. Scott K.W. Glutaraldehyde gel for warts. The Practitioner. 226:1982;1342-1343.
16. Hirose R., Hori M., Shukuwa T., et al. Topical treatment of resistant warts with glutaraldehyde. J Dermatol. 21:1994;248-253.
17. Steele K., Irwin W.G. Treatment options for cutaneous warts in family practice. Family Practice. 5:1988;314-319.
18. Vickers C.F.H. Treatment of plantar warts in children. Br Med J. ii:1961;743-745.
19. Duthie D.A., McCallum D.I. Treatment of plantar warts with elastoplast and podophyllin. Br Med J. 2:1951;216-218.
20. Coskey R.J. Treatment of plantar warts in children with a salicylic acid-podophyllin-cantharidin product. Pediatr Dermatol. 2:1984;71.
21. Hays M.E., O'Keefe E.J. Reduced dose of bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol. 15:1986;1002-1006.
22. Shelley W.B., Shelley D.E. Intralesional bleomycin sulfate therapy for warts. Arch Dermatol. 127:1991;234-236.
23. Abel E.A. Immunosuppressant and cytotoxic drugs Unapproved uses or indications . Clin Dermatol. 18:2000;95-101.
24. Spiro J.M. Technique for treatment of resistant warts using bleomycin by vaccination. Cutis. 57:1996;180-182.
25. Van-Der-Velden E.M., Ijsselmuiden O.E., Drost B.H., et al. Dermatography with bleomycin as a new treatment for verrucae vulgaris. Int J Dermatol. 36:1997;145-150.
26. Inui S., Asada H., Wataya-Kaneda M., et al. OK-432 therapy for recalcitrant warts. J Dermatol. 24:1997;301-305.
27. Conant M. Immunomodulatory therapy in the management of viral infections in patients with HIV infection. J Am Acad Dermatol. 43:2000;S27-30.
28. Hengge U.R., Goos M., Arndt R. Topical treatment of warts and mollusca with imiquimod. Ann Int Med. 132:2000;95.
29. Duan J., Paris W., De-Marte J., et al. Topical effects of cidofovir on cutaneous rabbit warts treatment regimen and inoculum dependence . Antiviral Res. 46:2000;135-144.
30. Zabawski E.J., Sands B., Goetz D. Treatment of verruca vulgaris with topical cidofovir. JAMA. 278:1997;1236.
31. Davis M.D.P., Gostout B.S., McGovern R.M., et al. Large plantar wart caused by human papillomavirus-66 and resolution by topical cidofovir therapy. J Am Acad Dermatol. 43:2000;340-343.
32. Lewis H.M. Topical immunotherapy of refractory warts. Cutis. 12:1973;863-867.
33. Lahti A., Hannuksela M. Topical immunotherapy with tuberculin jelly for common warts. Arch Dermatol Res. 273:1982;153-154.
34. Buckley D.A., Du Vivier A.W.P. The therapeutic use of topical contact sensitizers in benign dermatoses. Br J Dermatol. 145:2001;385-405.
35. Johanson E., Forstrom L. Dinitrochlorobenzene (DNCB) treatment of viral warts. Acta Derm Venereol. 64:1984;529-533.
36. Malek-Mansour S., Castermans-Elias S., Lapiere C.M. Regression de metastase de melanome apres therapeutic immunologique. Dermatologica. 146:1973;256-262.
37. Claudy A.L., Roche H. Traitement des verrues multiples et recidivantes par induction d' une hypersensibilite retardee. Etude critique de l' utilisation du dibutilester de l' acid squarique . Ann Dermatol Venereol. 108:1981;765-767.
38. Naylor M.F., Neldner K.H., Yarbrough G.K., et al. Contact immunotherapy of resistant warts. J Am Acad Dermatol. 19:1988;679-683.
39. Buckley D.A., Keane F.M., Munn S.E., et al. Recalcitrant viral warts treated by diphencyprone immunotherapy. Br J Dermatol. 141:1999;292-296.
40. Orecchia G., Douville H., Santagostino I., Rabbiosi G. Treatment of multiple relapsing warts with diphencyprone. Dermatologica. 177:1988;225-231.
41. Lane P.R., Hogan D.J. Diphencyprone. (letter) J Am Acad Dermatol. 19:1988;364-365.
42. Dunagin W.G., Millikan L.E. Dinitrochlorobenzene immunotherapy for verrucae resistant to standard treatment modalities. J Am Acad Dermatol. 6:1982;40-45.
43. Eriksen K. Treatment of the common wart by induced allergic inflammation. Dermatologica. 160:1980;161-166.
44. Iijima S., Otsuka F. Contact immunotherapy with squaric acid dibutyl ester for warts. Dermatology. 187:1993;115-118.
45. Micali G., Dall'Oglio F., Tedeschi A., et al. Treatment of cutaneous warts with squaric acid dibutylester A decade of experience . Arch Dermatol. 42:2000;557-558.
46. Silverberg N.B., Lim J.K., Paller A.S., Mancini A.J. Squaric acid immunotherapy of human warts in children. J Am Acad Dermatol. 42:2000;803-808.
47. Sanders B.B., Smith K.W. Dinitrochlorobenzene immunotherapy of human warts. Cutis. 27:1981;389-392.
48. Smetana Z., Malik Z., Orenstein A., et al. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med. 21:1997;351-358.
49. Stender I.M., Andersen J.L., Wulf H.C. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolevulinic acid a pilot study . Clin Exp Dermatol. 24:1999;154-159.
50. Stender I.M., Na R., Fogh H., et al. Photodynamic therapy with 5-aminolevulinic acid or placebo for recalcitrant foot and hand warts randomized double-blind trial . Lancet. 355:2000;963-966.
51. Stender I.M., Wulf H.C. Photodynamic therapy of recalcitrant warts with 5-aminolevulinic acid A retrospective analysis . Acta Derm Venereol. 79:2000;400-401.
52. Stern P., Levine N. Controlled localized heat therapy in cutaneous warts. Arch Dermatol. 128:1992;945-948.
53. Tonsy E.I., Anbar T.E., El-Domyati E.I., Bakarat M. Density of viral particles in pre and post Nd-YAG laser hyperthermia therapy and cryotherapy in plantar warts. Int J Dermatol. 38:1999;393-398.
54. Sloan K., Haberman H., Lynde C.W. Carbon dioxide laser treatment of resistant verrucae vulgaris A retrospective analysis . J Cutan Med Surg. 2:1998;142-145.
55. 2 and PLDL pulsed dye lasers. Plast Rec Surg. 100:1998;2010-2011.
56. Jacobsen E., McGraw R., McCagh S. Pulsed dye laser efficacy as initial therapy for warts and against recalcitrant verrucae. Cutis. 59:1997;206-208.
57. Kenton-Smith J., Tan S.T. Pulsed dye laser therapy for viral warts. Br J Plast Surg. 52:1999;554-558.
58. Robson K.J., Cunningham N.M., Kruzan K.L., et al. Pulsed-dye laser versus conventional therapy in the treatment of warts A prospective randomized trial . J Am Acad Dermatol. 43:2000;1612.
59. Mixter RC, Carson LV, Walton BJ, Gerson RW. Treatment of recalcitrant verrucae with both the ultrapulse CO2 and PLDL pulsed dye lasers. Plast Rec Surg 1997;Nov:1612.
60. Jain A., Storwick G.S. Effectiveness of the 585nm flashlamp-pulsed tunable dye laser (PLDL) for the treatment of plantar verrucae. Lasers Surg Med. 21:1997;500-505.
61. Gooptu C., James M.P. Recalcitrant viral warts results of treatment with the KTP laser . Clin Exp Dermatol. 24:1999;60-63.
62. Rogers C.J., Gibney M.D., Siegfried E.C., et al. Cimetidine therapy for recalcitrant warts in adults Is it any better than placebo? J Am Acad Dermatol. 41:1999;123-127.
63. Orlow S.J., Paller A. Cimetidine therapy for multiple viral warts in children. J Am Acad Dermatol. 28:1993;794-796.
64. Glass A.T., Solomon B.A. Cimetidine therapy for recalcitrant warts in adults. Arch Dermatol. 132:1996;680-682.
65. Fischer G., Rogers M. Cimetidine therapy for warts in children. J Am Acad Dermatol. 37:1997;289-290.
66. Gooptu C., Higgins C.R., James M.P. Treatment of viral warts with cimetidine An open-label study . Clin Exp Dermatol. 25:2000;183-185.
67. Yilmaz E., Alpsoy E., Basaran E. Cimetidine therapy for warts A placebo-controlled, double-blind study . J Am Acad Dermatol. 34:1996;1005-1007.
68. Karabulut A.A., Sahin S., Eksioglu M. Is cimetidine effective for non-genital warts A double blind, placebo-controlled study . Arch Dermatol. 133:1997;533-534.
69. Bauman C., Francis J.S., Vanderhooft S., Sybert V. Cimetidine therapy for multiple viral warts in children. J Am Acad Dermatol. 35:1996;271-272.
70. Saenz-Santamarie M.C., Gilaberte Y. Cimetidine and warts. Arch Dermatol. 133:1997;530-531.
71. Am M., Tosson Z., Soliman A., et al. Verrucae treated by levamisole. Int J Dermatol. 30:1991;738-740.
72. Saul A., Sanz R., Gomez M. Treatment of multiple viral warts with levamisole. Int J Dermatol. 19:1980;342-343.
73. Schou M., Helin P. Levamisole in a double-blind study No effect on warts . Acta Derm Venereol. 57:1977;449-454.
74. Parsad D., Saini R., Negi K.S. Comparison of combination of cimetidine and levamisole with cimetidine alone in the treatment of recalcitrant warts. Australas J Dermatol. 40:1999;93-95.
75. Gibson J.R., Harvey S.C., Kemmet D., et al. Treatment of common and plantar viral warts with human lymphoblastoid interferon-alpha-pilot studies with intralesional, intramuscular and dermojet injections. Br J Dermatol. 40:1999;76-79.
76. Brodell R.T., Bredle D.L. The treatment of palmar and plantar warts using natural alpha interferon and a needless injector. Dermatol Surg. 21:1995;213-218.
77. Shenefelt P.D. Hypnosis in dermatology. Arch Dermatol. 136:2000;393-399.
78. Spanos N.P., Stenstrom R.J., Johnnston J.C. Hypnosis, placebo and suggestion in the treatment of warts. Psychosom Med. 50:1988;245-260.
79. Kainz J.T., Kozel G., Haidvogl M., Smolle J. Homoeopathic versus placebo therapy of children with warts on the hands A randomized, double-blind clinical trial . Dermatology. 193:1996;318-320.
80. Harkness E.F., Abbot N.C., Ernst E. A randomized trial of distant healing for skin warts. Am J Med. 108:2000;448-452.
81. Martin A.G., Kobayashi G.S. Superficial fungal infection Dermatophytosis, Tinea nigra, Piedra . Freedberg I.M., Eisen A.Z., Wolf K., et al. 5th ed. Dermatology in general medicine. 108:2000;2337-2357 McGraw Hill, New York.
82. McClellan K.J., Wiseman L.R., Markham A. Terbinafine. An update of its use in superficial mycoses. Drugs. 58:1999;1277-1376.
83. Hay R.J., Moore M. Mycology. Champion R.H., Burton J.L., Burns D.A., Breathnach S.M. Rook/Wikinson/Ebling Textbood of Dermatology. Vol. 2:1998;1277-1376 Blackwell Science.
84. McNeely W., Spencer C.M. Butenafine. Drugs. 55:1998;405-412.
85. Lescher J.L. Oral therapy of common superficial fungal infections of the skin. J Am Acad Dermatol. 40:1999;S31-34.
86. De-Doncker P, Gupta AK. Itraconazole and terbinafine in perspective. From petri dish to patient. Postgrad Med 1999;SpecNo6-11.
87. Gooskens V., Ponnighaus J.M., Layton Y., et al. Treatment of superficial mycoses in the tropics Whitfield's ointment versus clotrimazole . Int J Dermatol. 33:1994;738-742.
88. British National Formulary. Antifungal Preparations: Undecenoates. 1999:520.
89. Birch CA. Castellani's paint: Sir Aldo Castellani. Practitioner 1974;212:895-892.
90. Tanuma H. Pathogenesis and treatment of hyperkeratotic tinea pedis in Japan. Mycoses. 42:1999;21-28.
91. Nakajima T., Sato H., Izima M. Combination effect of salicylic acid on antifungal activity of tolnaftate preparation (ZM-589). Jpn J Med Mycol. 34:1993;27-34.
92. Nakajima T., Nakazawa C., Yonara Y. Effect of salicylic acid of the penetration of tolnaftate and histological changes in the skin. Arch Pract Pharmacy. 52:1992;160-165.
93. Tanuma H., Doi M., Sato N., et al. Bifonazole (Mycospor cream) in the treatment of moccasin-type tinea pedis. Comparison between combination therapy of bifonazole cream+10% urea ointment (Urepearl) and occlusive dressing therapy with the same agents. Mycoses. 43:2000;129-137.
94. Weller R., Price R., Ormerod A., et al. Antimicrobial effects of acidified nitrate on skin commensals and pathogens. (abstract) Br J Dermatol. 136:1997;464.
95. Weller R., Ormerod A.D., Hobson R.P., Benjamin N.J. A randomized trial of acidified nitrate cream in the treatment of tinea pedis. J Am Acad Dermatol. 38:1998;559-563.
96. Shahi S.K., Shukla A.C., Bajaj A.K., et al. Broad spectrum herbal therapy against superficial fungal infections. Skin Pharmacol Appl Skin Physiol. 13:2000;60-64.
97. Dikshit A., Dixit S.N. Cedrus oil - A promising antifungal agent. Indian Perfumer. 26:1982;216-227.
98. Pandey M.C., Sharma J.R., Dikshit A. Antifungal evaluation of the essential oil of Cymbopogon pendulus (Nees ex Steud). Wats var Parman Flavor Fragrance J. 11:1996;257-260.
99. Shahi SK. Antimycotic Studies of Some Plants (Control of Dermatophytoses in Human Beings); thesis, Allahabad 1997.
100. Shahi S.K., Shukla A.C., Pandey M.C. In vitro and vivo studies of Trachyspermum ammi against human pathogenic fungi. (abstract) Proc 90th All India Botanical Conference. 75:1996;50.
101. Shahi S.K., Shulka A.C., Bajaj A.K., et al. Broad spectrum antimycotic drug for the control of fungal infection in human beings. Curr Sci. 76:1999;836-839.
102. Yamauchi K., Hiruma M., Yamazaki N., et al. Oral administration of bovine lactoferrin for treatment of tinea pedis. A placebo-controlled, double-blind study. Mycoses. 43:2000;197-202.
103. Watanabe K., Taniguchi H., Katoh T. Adhesion of dermatophytes to healthy feet and its simple treatment. Mycoses. 43:2000;45-50.
104. Christophers E., Mrowietz U. Pustular eruptions of palms and soles. Freedberg I.M., Eisen A.Z., Wolf K., et al. Fitzpatrick's dermatology in general medicine. 5th ed. 2000;723-728 McGraw Hill, New York.
105. Murray D., Warin A.P. Photochemotherapy for persistent palmoplantar pustulosis (PPP). Br J Dermatol. 101:(suppl):1979;13-14.
106. Lassus A., Lauharanta J., Eskelinen A. The effect of etretinate compared with different regimes of PUVA in the treatment of persistent palmoplantar pustulosis. Br J Dermatol. 112:1985;455-459.
107. White S.I., Puttick L., Marks J.M. Low-dose etretinate in the maintenance of remission of palmoplantar pustular psoriasis. Br J Dermatol. 115:1986;577-582.
108. Rosen K., Mobacken H., Swanberg G. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmaris and plantaris. Arch Dermatol. 123:1987;885-889.
109. Lassus A., Geiger J.M. Acitretin and etretinate in the treatment of palmoplantar pustulosis A double-blind comparative trial . Br J Dermatol. 119:1988;755-759.
110. Sadick N.S. Antibiotics Unapproved uses or indications . Clin Dermatol. 18:2000;11-16.
111. Ward J.M., Corbett M.F., Hanna M.J. A double-blind trial of clomocycline in the treatment of persistent palmoplantar pustulosis. Br J Dermatol. 95:1976;317-322.
112. Tagigawa M., Miyachi Y., Uehara M., et al. Treatment of pustulosis palmaris and plantaris with oral doses of colchicine. Arch Dermatol. 118:1982;458-460.
113. Thestrup-Petersen K., Reymann F. Treatment of pustulosis palmaris and plantaris with colchicine. A double-blind cross-over trial. Acta Derm Venereol. 64:1984;76-78.
114. Capella G.L., Finzi A.F. Psoriasis, lichen planus, and disorders of keratinization Unapproved treatments or indications . Clin Dermatol. 18:2000;159-169.
115. Molin L. Clofazamine-enhanced phagocytosis in pustulosis palmaris et plantaris. Acta Derm Venereol. 55:1975;151-153.
116. Lang P.G. Sulfones and sulfonamides in dermatology today. J Am Acad Dermatol. 1:1979;479-492.
117. Ridley M. Pustular psoriasis. Br J Dermatol. 105:(suppl. 19):1981;39-40.
118. Thomsen K. Pustulosis palmaris et plantaris treated with methotrexate. Acta Derm Venereol. 51:1971;397-400.
119. Hattel T., Sondergaard J. Pustulosis palmaris et plantaris treated with hydroxyurea. Acta Derm Venereol. 54:1974;152-154.
120. Robinson T.W.E. The treatment of pustular dermatoses of the extremities with oral triamcinolone. Br J Dermatol. 78:1966;158-160.
121. Reitamo S., Puska P., Lassus A. Cyclosporine in the treatment of palmoplantar pustulosis. Br J Dermatol. 120:1989;857.
122. Meinardi M.M.H.M., De Rie M.A., Bos J.D. Oral cyclosporine is effective in clearing persistent pustulosis palmaris et plantaris. Acta Derm Venereol. 70:1990;77-81.
123. Reitamo S., Erkko P., Remitz A., et al. Cyclosporine in the treatment of palmoplantar pustulosis A randomized double-blind, placebo-controlled study . Arch Dermatol. 129:1993;1273-1279.
124. Erkko P., Granlund H., Remitz A., et al. Double-blind placebo-controlled study of long-term low-dose cyclosporine in the treatment of palmoplantar pustulosis. Br J Dermatol. 139:1998;997-1004.
125. Kirby B., Griffiths C.E.M. Psoriasis The future . Br J Dermatol. 144:(suppl 58):2001;37-43.
126. Bhushan M., Burden A.D., McElhone K., et al. A double-blind placebo-controlled study of oral liarozole in the treatment of palmoplantar pustular psoriasis. (abstract) Br J Dermatol. 141:1999;978.
127. Dockx P., Decree J., Degreef H. Inhibition of the metabolism of endogenous retinoic acid as treatment for psoriasis An open study with liarozole . Br J Dermatol. 133:1995;426-432.
128. Arechalde A., Saurat J.H. Retinoids Unapproved uses or indications . Clin Dermatol. 18:2000;63-76.
129. Ledo E., Ledo A. Phototherapy, photochemotherapy, and photodynamic therapy Unapproved uses or indications . Clin Dermatol. 18:2000;77-86.
130. Boehncke W.H., Schmidt T.E., Kaufmann R. Systemic photodynamic therapy is a safe and effective treatment for psoriasis. Arch Dermatol. 136:2000;271-272.
131. Camp R.D.R. Psoriasis. Champion R.H., Burton J.L., Burns D.A., et al. Rook textbook of dermatology. 6th ed. 2000;1589-1649 Blackwell Science, Oxford.
132. Lebwohl M., Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol. 45:2001;487-498.
133. Asawanonda P., Anderson R.R., Chang Y., Taylor C.R. 308-nm excimer laser for the treatment of psoriasis. Arch Dermatol. 136:2000;619-624.
134. Van de Kerkhof P.C.M. New developments in the treatment of psoriasis. Skin Pharmacol Appl Skin Physiol. 14:2001;129-135.
135. Veien N.K., Bjerke J.R., Rossmann-Ringdahl I., Jakobsen H.B. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol A double-blind trial . Br J Dermatol. 137:1997;581-586.
136. Bourke J.F., Featherstone S., Igbal S.J., Hutchinson P.E. A double-blind comparison of topical calcitriol (3μg) and calcipotriol (50μg) in the treatment of chronic plaque psoriasis vulgaris. Br J Dermatol. 133:1995;17.
137. Barker J.N., Ashton R.E., Marks R., et al. Topical maxacalcitol for the treatment of psoriasis vulgaris A placebo-controlled, double-blind, dose finding study with active comparator . Br J Dermatol. 141:1999;274-278.
138. Zonneveld I.M., Rubins A., Jablonska S., et al. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol. 134:1998;1101-1102.
139. Mrowietz U., Graeber M., Brautigam M., et al. The novel azomycin derivative SDZ asm 981 is effective for psoriasis when used topically under occlusion. Br J Dermatol. 139:1998;992-996.
140. Zckheim H.S., Maibach H.I. Treatment of psoriasis with 6-thioguanine. Aust J Dermatol. 29:1988;163-167.
141. Campanile G., Hautmann G., Lotti T.M. Hyperhidrosis. Katsambas A.D., Lotti T.M. European Handbook of Dermatological Treatments. 1999;256-260 Springer, Berlin.
142. Adar R., Kurchin A., Zweig A., et al. Palmar hyperhidrosis and its surgical treatment a report of 100 cases . Ann Surg. 186:1977;34-41.
143. Freeman S. Shoe dermatitis. Contact Dermatitis. 36:1997;247-251.
144. Stolman L.P. Treatment of hyperhidrosis. Dermatol Clin. 16:1998;863-869.
145. Shelley W.B., Hurley H.J. Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Derm Venereol. 95:1975;241-260.
146. Benohanian A., Dansereau A., Bolduc C., et al. Localized hyperhidrosis treated with aluminium chloride in a salicylic acid gel base. Int J Dermatol. 37:1998;701-708.
147. Martindale W. The extra pharmacopoeia. 27th ed:1979;212-213 Pharmaceutical Press, London.
148. Seukeran D.C., Highet A.S. The use of topical glycopyrrolate in the treatment of hyperhidrosis. Clin Exp Dermatol. 23:1998;204-205.
149. Stolman L.P. Treatment of excess sweating of the palms by iontophoresis. Arch Dermatol. 123:1987;893-896.
150. Goldmith L.A. Disorders of the eccrine sweat gland. Freedberg I.M., Eisen A.Z., Wolff K., Fitzpatrick T.B., et al. Fitzpatrick's dermatology in general medicine. 1987;800-817 McGraw-Hill, New York.
151. Hashmonai M., Kopelman D., Assalia A. The treatment of primary palmar hyperhidrosis A review . Surg Today. 30:2000;211-218.
152. Duarte J.B., Kux P. Improvements in video-endoscopic sympathectomy for the treatment of palmar, axillary, facial and palmar-plantar hyperhidrosis. Eur J Surg Suppl. 580:1998;9-11.
153. Markey A.C. Botilinum A exotoxin in cosmetic dermatology. Clin Exp Dermatol. 25:2000;173-175.
154. Huang W., Foster J.A., Rogachefsky A.S. Pharmacology of botilinum toxin. J Am Acad Dermatol. 43:2000;249-259.
155. Benedetto A.V. Products in dermatologic surgery Unapproved treatments or indications . Clin Dermatol. 18:2000;219-228.
156. Naumann M., Hofmann U., Bergman I., Hamm H., et al. Focal hyperhidrosis. Effective treatment with intracutaneous Botilinum Toxin. Arch Dermatol. 134:1998;301-304.
157. Goldman A. Treatment of axillary and palmar hyperhidrosis with botilinum toxin. Aesthetic Plast Surg. 24:2000;280-282.
158. Wilkinson J.D. Vesicular palmoplantar eczema. Freedberg I.M., Eisen A.Z., Wolff K., et al. Fitzpatrick's dermatology in general medicine. 1999;1489-1494 McGraw Hill, New York.
159. LaVine M.J., Parrish J.A., Fitzpatrick T.B. Oral methoxsalen photochemotherapy (PUVA) of dyshidrotic eczema. Acta Derm Venereol. 61:1981;570-571.
160. Grattan C.E.H., Carmichael A.J., Shuttleworth G.J., Foulds I.S. Comparison of topical PUVA with UVB for chronic vesicular hand eczema. Acta DermVenereol. 71:1991;118-122.
161. Sheehan-Dare R.A., Goodfield M.J., Rowell N.R. Topicalpsoralen photochemotherapy (PUVA) and superficial radiotherapy in the treatment of chronic hand eczema. Br J Dermatol. 121:1989;65-69.
162. Granlund H., Erkko P., Eriksson E., Reitamo S. Comparison of cyclosporine and topical betamethasone-17, 21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol (Stockh). 76:1996;371-376.
163. Reitamo S., Granlund H. Cyclosporine in the treatment of chronic dermatitis of the hands. Br J Dermatol. 130:1994;75-78.
164. Egan C.A., Rallis T.M., Meadows K.P., Krueger G.G. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol. 40:1999;612-614.